Skip to main content

Table 3 Descriptive statistics by AD biomarker profiles for CSO-PVS and BG-PVS volumes (in ml) for four annual visits. Group-level results included subjects who had at least three scans available. We removed extreme values in volumes within the whole sample for each time point to lessen the influence of outliers and corrected estimates for age at the time of the scan

From: Perivascular space enlargement accelerates in ageing and Alzheimer’s disease pathology: evidence from a three-year longitudinal multicentre study

  

AD biomarker profile

  

A-T-

A+T-

A+T+

Baseline volume (ml)

CSO-PVS

1.93±0.13

1.63±0.22

1.60±0.25

BG-PVS

0.60±0.03

0.52±0.05

0.44±0.05

12-month follow-up volume (ml)

CSO-PVS

2.06±0.15

1.81±0.25

1.62±0.29

BG-PVS

0.62±0.03

0.54±0.05

0.51±0.05

24-month follow-up volume (ml)

CSO-PVS

1.92±0.14

1.89±0.23

1.85±0.26

BG-PVS

0.63±0.03

0.55±0.05

0.50±0.05

36-month follow-up volume (ml)

CSO-PVS

2.12±0.17

1.87±0.29

1.99±0.36

BG-PVS

0.63±0.03

0.54±0.05

0.54±0.07

Annual changea of PVS (in ml/year)

CSO-PVS

0.04±0.04

0.08±0.03

0.14±0.03

BG-PVS

0.01±0.00

0.01±0.01

0.03±0.01

Annual change a of PVS from baseline (in %/year)

CSO-PVS

2.21

4.76

9.03

BG-PVS

1.59

1.26

6.61

  1. Annotations. Mean ± standard error;
  2. aChange of PVS volumes per AD biomarker group was estimated based on linear approximations